A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
- PMID: 12393516
- DOI: 10.1182/blood-2002-07-2170
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Abstract
Fanconi anemia (FA) is an autosomal recessive disorder characterized by cellular hypersensitivity to DNA cross-linking agents and cancer predisposition. Recent evidence for the interactions of ataxia-telangiectasia mutated protein ATM and breast cancer susceptibility proteins BRCA1 and BRCA2 (identified as FANCD1) with other known FA proteins suggests that FA proteins have a significant role in DNA repair/recombination and cell cycle control. The International Fanconi Anemia Registry (IFAR), a prospectively collected database of FA patients, allows us the unique opportunity to analyze the natural history of this rare, clinically heterogeneous disorder in a large number of patients. Of the 754 subjects in this study, 601 (80%) experienced the onset of bone marrow failure (BMF), and 173 (23%) had a total of 199 neoplasms. Of these neoplasms, 120 (60%) were hematologic and 79 (40%) were nonhematologic. The risk of developing BMF and hematologic and nonhematologic neoplasms increased with advancing age with a 90%, 33%, and 28% cumulative incidence, respectively, by 40 years of age. Univariate analysis revealed a significantly earlier onset of BMF and poorer survival for complementation group C compared with groups A and G; however, there was no significant difference in the time to hematologic or nonhematologic neoplasm development between these groups. Multivariate analysis of overall survival time shows that FANCC mutations (P =.007) and hematopoietic stem cell transplantation (P = <.0001) define a poor-risk subgroup. The results of this study of patients registered in the IFAR over a 20-year period provide information that will enable better prediction of outcome and aid clinicians with decisions regarding major therapeutic modalities.
Comment in
-
Cancer in Fanconi anemia.Blood. 2003 Mar 1;101(5):2072. doi: 10.1182/blood-2002-11-3597. Blood. 2003. PMID: 12584146 No abstract available.
Similar articles
-
Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.Blood. 1997 Jul 1;90(1):105-10. Blood. 1997. PMID: 9207444
-
Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.Ann Hematol. 2019 Feb;98(2):271-280. doi: 10.1007/s00277-018-3517-0. Epub 2018 Oct 27. Ann Hematol. 2019. PMID: 30368588
-
Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.Hum Mutat. 2005 Feb;25(2):142-9. doi: 10.1002/humu.20125. Hum Mutat. 2005. PMID: 15643609
-
Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.Cancer Genet Cytogenet. 1991 Jan;51(1):1-12. doi: 10.1016/0165-4608(91)90002-c. Cancer Genet Cytogenet. 1991. PMID: 1984836 Review.
-
Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.Int J Hematol. 2001 Jul;74(1):33-41. doi: 10.1007/BF02982547. Int J Hematol. 2001. PMID: 11530803 Review.
Cited by
-
Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.Oral Dis. 2015 Jul;21(5):593-601. doi: 10.1111/odi.12321. Epub 2015 Apr 6. Oral Dis. 2015. PMID: 25662766 Free PMC article.
-
The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.Haematologica. 2015 May;100(5):633-42. doi: 10.3324/haematol.2014.117457. Epub 2015 Feb 14. Haematologica. 2015. PMID: 25682607 Free PMC article.
-
TNF-α signaling in Fanconi anemia.Blood Cells Mol Dis. 2014 Jan;52(1):2-11. doi: 10.1016/j.bcmd.2013.06.005. Epub 2013 Jul 24. Blood Cells Mol Dis. 2014. PMID: 23890415 Free PMC article. Review.
-
Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene.J Med Genet. 2016 Oct;53(10):672-680. doi: 10.1136/jmedgenet-2016-103847. Epub 2016 May 20. J Med Genet. 2016. PMID: 27208205 Free PMC article.
-
Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.Blood. 2007 Mar 1;109(5):2256-62. doi: 10.1182/blood-2006-07-036657. Epub 2006 Oct 12. Blood. 2007. PMID: 17038525 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous